WHO boss says vaccine IP waiver not a property 'snatch' | Inquirer News

WHO boss says vaccine IP waiver not a property ‘snatch’

/ 12:19 PM July 22, 2021

Tedros Adhanom Ghebreyesus

World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus AFP FILE PHOTO

GENEVA — The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on Covid-19 vaccines was not a bid to “snatch” their intellectual property rights.

With more than four million dead and the toll likely to reach much higher, WHO Director-General Tedros Adhanom Ghebreyesus said vaccine makers should be offered incentives in return for temporarily waiving their the rights.

Article continues after this advertisement

“Of course, we can’t snatch your property,” Tedros said via video link from Tokyo at the start of a meeting with the World Trade Organization, pharma companies and global financial institutions.

FEATURED STORIES

“With so many lives on the line, profits and patents must come second,” he said, without giving any details on the proposed financial incentives.

Waiving intellectual property rights would help meet the 11 billion doses of vaccine the WHO says are needed to protect 70 percent of people in every country by mid-2022.

Article continues after this advertisement

This is the second meeting in Geneva to try to bridge differences on how to increase supply of jabs and cut the vaccine inequity that sees rich countries eyeing booster shots while health workers in poor countries go without.

Article continues after this advertisement

Of the 1.1 billion doses produced globally in June, “only 1.4 percent went to Africans, who account for 17 percent of the global population”, WTO Director-General Ngozi Okonjo-Iweal said in her opening speech.

Article continues after this advertisement

“Only 0.24 percent went to people in low-income countries. And both shares declined even further in the first half of July,” she said.

In addition to the suspension of patents, barriers to the trade in vaccine ingredients must be removed and laboratories agree to transfer their technology, Tedros said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.